Rhamnaceae
Rhamnaceae is a large family of flowering plants, commonly known as the buckthorn family. The family includes about 55 genera and 900 species, which are widespread in tropical and subtropical regions, with a few species extending into temperate zones.
Description[edit]
Members of the Rhamnaceae family are typically shrubs, trees, or vines. They are characterized by simple, alternate or opposite leaves that lack stipules, and flowers that are often small and greenish. The flowers are typically radially symmetric and can be either unisexual or bisexual.
Taxonomy[edit]
The Rhamnaceae family is classified within the order Rosales, which also includes families such as Rosaceae and Moraceae. The family is divided into several subfamilies, including Rhamnoideae, Ziziphoideae, Gouanieae, and Ampelozizyphoideae.
Distribution and habitat[edit]
Species in the Rhamnaceae family are found in a wide range of habitats, from tropical rainforests to desert conditions. They are particularly common in Australia, South Africa, and the Americas.
Uses[edit]
Many species in the Rhamnaceae family have economic importance. For example, some species are used for timber, while others are cultivated for their ornamental value. Some species also have medicinal uses.
See also[edit]
References[edit]
External links[edit]
- Rhamnaceae in L. Watson and M.J. Dallwitz (1992 onwards). The families of flowering plants: descriptions, illustrations, identification, information retrieval. Version: 3 May 2006. http://delta-intkey.com.
Rhamnaceae[edit]
-
Rhamnus pumila
-
Ceanothus cuneatus
-
Helinus integrifolius
-
Ziziphus mucronata
-
Rhamnus saxatilis
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
